Breaking News: Cingulate Successfully Closes $4.0 Million Public Offering – A Major Milestone Achieved!
Impact of Cingulate’s Public Offering Announcement A Look at Cingulate Inc.’s Public Offering Recently, Cingulate Inc. (NASDAQ: CING) announced the closing of its $4.0 million public offering. This biopharmaceutical company is known for utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to develop next-generation pharmaceutical products. The successful completion of this public…